Novartis’ Intravenous Formulation of Cosentyx Impacting Prescriber Preferences in Psoriatic Arthritis Treatment, While Pending Launch of UCB’s Bimzelx Poised to Further Disrupt the Market
16. April 2024 14:06 ET
|
Spherix Global Insights
EXTON, PA, April 16, 2024 (GLOBE NEWSWIRE) -- In October of 2023, the US FDA approved Novartis’ intravenous (IV) formulation of Cosentyx (secukinumab) for the treatment of psoriatic arthritis (PsA),...
Global Ankylosing Spondylitis Market is Projected to Reach $7.29 Billion by 2027: Leading Players Pfizer, AbbVie, and Novartis Drive Advances in Treatment Options
12. Oktober 2023 07:03 ET
|
Research and Markets
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The "Ankylosing Spondylitis Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global ankylosing spondylitis...
Axial Spondyloarthritis Management Market is expected to reach US$ 7.3 Billion, & expected to grow with a 5.1% CAGR during 2023 to 2033 | Future Market Insights, Inc.
31. März 2023 07:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, March 31, 2023 (GLOBE NEWSWIRE) -- During the forecast period 2023 to 2033, the Axial Spondyloarthritis management market is expected to grow at a value of 5.1% CAGR, according to...
Global Ankylosing Spondylitis Market to Surpass US$ 8,460.7 Million by 2028, Says Coherent Market Insights (CMI)
20. Januar 2022 08:35 ET
|
CMI
SEATTLE, Jan. 20, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global ankylosing spondylitis market is estimated to be valued at US$ 4,864.3 million in 2021 and is expected to...
Global Axial Spondyloarthritis (axSpA) Market Landscape Report 2021: Pfizer Leads Industry Sponsors with the Highest Overall Number of Clinical Trials, Followed by AbbVie
11. Juni 2021 05:28 ET
|
Research and Markets
Dublin, June 11, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Axial Spondyloarthritis (axSpA)" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the...
New Drugs for Ankylosing Spondylitis Treatment Coming Down the Pipeline: An Updated Clinical Status by DelveInsight
15. April 2021 20:40 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, April 15, 2021 (GLOBE NEWSWIRE) -- New Drugs for Ankylosing Spondylitis Treatment Coming Down the Pipeline: An Updated Clinical Status by DelveInsight Around 30+ notable...
Global Ankylosing Spondylitis Market Outlook Report 2019-2027: Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities
21. Dezember 2020 10:53 ET
|
Research and Markets
Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "Ankylosing Spondylitis - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global Ankylosing Spondylitis...
Global Ankylosing Spondylitis Market Outlook to 2027: High Treatment Cost and Lack of Skilled Surgeons and Physiotherapists are Hampering Market Growth
04. November 2020 04:43 ET
|
Research and Markets
Dublin, Nov. 04, 2020 (GLOBE NEWSWIRE) -- The "Ankylosing Spondylitis - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global Ankylosing Spondylitis...
Autoimmune Disease Diagnostics Market worth over $16 Billion by 2024: Global Market Insights, Inc.
19. Oktober 2017 07:00 ET
|
Global Market Insights, Inc
Ocean View, Delaware, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Autoimmune Disease Diagnostics Market is expected to cross USD 16 billion by 2024; according to a new research report by Global Market...
Autoimmune Disease Diagnostics Market size worth USD 15 Billion by 2023: Global Market Insights Inc.
13. Juli 2016 11:00 ET
|
Global Market Insights
Ocean View, Delaware, July 13, 2016 (GLOBE NEWSWIRE) -- Autoimmune Disease Diagnostics Market size is estimated to reach USD 15.7 billion by 2023; as per a new research report by Global Market...